Answers are grounded in this paper and cite their sources.
Purpose The aim of this study was to investigate the optical coherence tomography (OCT) parameters that can predict the vision of patients with exudative age-related macular degeneration (AMD) 1 month following intravitreal ranibizumab injection. Patients and methods This is a prospective consecutive case-series study that was conducted on 20 eyes of 18 consecutive patients who received intravitreal ranibizumab injection for exudative AMD. A spectral-domain OCT imaging was done just before and 1 month following the injection. The main outcome measures were the correlations between the postinjection vision and the preinjection OCT parameters. Results A significant reduction was noted in retinal volume at the 3 and 5-mm central circles. The reduction in retinal thickness was statistically significant, while the reduction in other OCT parameters was insignificant. There was a strong correlation between postinjection vision and each of the following: foveal volume at 1 mm, full retinal thickness at the fovea, and retinal pigment epithelium elevation at the fovea ( r >0.7, P <0.05). Multivariate analysis showed that the foveal volume ( r 2 =0.538) was the most important predictor factor for visual acuity, 1 month following ranibizumab injection. Conclusions Foveal volume is the most important factor for vision prediction and can be used as an early visual predictor 1 month following ranibizumab injection in patients with AMD.
No takes yet. Share an insight, caveat, or question.
Sayed et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: